| Literature DB >> 26798478 |
Yorg Al Azzi1, Etti Zeldis1, Girish N Nadkarni1, Harry Schanzer2, Jaime Uribarri1.
Abstract
BACKGROUND: In the last few years, peritoneal dialysis (PD) catheter placement techniques and outcomes have become important because of the growing population of PD patients. Although there are a growing number of catheters placed by the minimally invasive Y-TEC peritoneoscopic technique, there are still limited data on outcomes for these catheters, especially those placed by a surgeon. We aimed to conduct a retrospective study of our experience with PD catheters placed by the Y-TEC peritoneoscopic technique in our institution.Entities:
Keywords: CAPD; catheter; peritoneal dialysis; peritoneal membrane; peritoneoscopy
Year: 2015 PMID: 26798478 PMCID: PMC4720193 DOI: 10.1093/ckj/sfv113
Source DB: PubMed Journal: Clin Kidney J ISSN: 2048-8505
Baseline characteristics of patients overall and stratified by catheter loss (n = 155)
| Overall | Patients with Y-TEC peritoneoscopic catheter placement ( | Patients with open catheter placement ( | P-value | |
|---|---|---|---|---|
| Age (years), mean (SD) | 55.1 (17.1) | 56.5 (17.9) | 54.2 (16.6) | 0.42 |
| Male, | 79 (51) | 36 (59) | 42 (45.2) | 0.09 |
| Race, | 0.39 | |||
| White | 98 (63.2) | 36 (59) | 58 (62.4) | 0.68 |
| African American/other | 57 (36.8) | 24 (41) | 35 (37.6) | |
| Body mass index, median (IQR) | 26 (23–30) | 25 (22–28) | 27.5 (24–32) | 0.02 |
| Cause of ESRD, | 0.10 | |||
| Diabetes | 50 (32.3) | 13 (21.3) | 37 (39.8) | |
| Hypertension | 35 (22.6) | 18 (29.5) | 16 (17.2) | |
| Glomerulonephritis/HIVAN | 37 (23.9) | 17 (27.9) | 20 (21.5) | |
| Other | 33 (21.3) | 14 (21.5) | 20 (21.5) | |
| PD as first modality | 103 (66.5) | 42 (67.7) | 60 (64.5) | 0.58 |
| Time to first use, | 0.10 | |||
| ≥2 months | 130 (83.9) | 48 (77.4) | 82 (88.1) | |
| <2 months | 19 (12.3) | 10 (16.1) | 9 (9.7) | |
| Unknown/never used | 6 (3.8) | 4 (6.5) | 2 (2.2) | |
| Prior abdominal surgery, | 3 | 0 (0) | 3 (3.2) | 0.17 |
Other causes of ESRD included interstitial nephritis (n = 2), amyloidosis (n = 2), medication induced (n = 6), polycystic kidney disease (n = 5), congenital (n = 3), sickle-cell disease (n = 1), chronic rejection post-transplant (n = 1), acute kidney injury (n = 2) and unknown (n = 11).
IQR, interquartile range; HIVAN, HIV-associated nephropathy.
Infectious and noninfectious catheter complications with associated catheter loss
| Total, | Patients with Y-TEC peritoneoscopic catheter placement ( | Patients with open catheter placement ( | P-value | |
|---|---|---|---|---|
| Infectious complications | ||||
| Only peritonitis | 55 | 16 (26) | 39 (42) | 0.05 |
| Exit site infection | 27 | 10 (16.1) | 17 (18.3) | 0.45 |
| Tunnel infection | 11 | 3 (5) | 8 (8.6) | 0.80 |
| Noninfectious complications | ||||
| Scrotal leak | 7 | 3 (4.8) | 4 (4.3) | 0.34 |
| Hernias | 3 | 0 (0) | 3 (3.2) | 0.55 |
| Catheter migration | 2 | 0 (0) | 2 (2.2) | 0.90 |
| Subcutaneous hematoma | 2 | 1 (1.6) | 1 (1.1) | 0.54 |
| Adhesions | 2 | 1 (1.6) | 1 (1.1) | 0.54 |
| Omental adherence | 2 | 1 (1.6) | 1 (1.1) | 0.54 |
| Pleuroperitoneal fistula | 1 | 0 (0) | 1 (1.1) | 0.90 |
Multivariable Cox proportional hazards for catheter loss
| Hazard ratio (95% CI) | P-value | |
|---|---|---|
| Peritoneoscopic placement | 1 (Ref) | NA |
| Open placement | 2.53 (0.98–6.68) | 0.06 |
| Age | 0.99 (0.96–1.02) | 0.79 |
| Female | 1 (Ref) | |
| Male | 1.02 (0.42–2.46) | 0.82 |
| White | 1 (Ref) | NA |
| African/American or other | 0.65 (0.25–1.72) | 0.39 |
| Diabetes mellitus | 1.06 (0.41–2.71) | 0.91 |
| Body mass index | 1.07 (0.99–1.16) | 0.08 |
Fig. 1.Catheter cumulative survival stratified by placement technique. This figure shows Kaplan–Meier curves for catheter loss by catheter placement technique. The solid red line denotes open placement of catheters, while the dotted green line denotes peritoneoscopic placement over the follow-up period in months. The two vertical maroon lines denote time intervals of 1 and 2 years of follow-up.